LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Scala, Carolina"
  2. AU="Rasmussen, Jan A"

Search results

Result 1 - 10 of total 56

Search options

  1. Article ; Online: Ultrasonographic 3D Evaluation in the Diagnosis of Bladder Endometriosis: A Prospective Comparative Diagnostic Accuracy Study.

    Barra, Fabio / Alessandri, Franco / Scala, Carolina / Ferrero, Simone

    Gynecologic and obstetric investigation

    2021  Volume 86, Issue 3, Page(s) 299–306

    Abstract: Objective: The use of three-dimensional (3D) transvaginal ultrasonography (TVS) has been investigated for the diagnosis of deep endometriosis (DE). This study aimed to evaluate if 3D reconstructions improve the performance of TVS) in assessing the ... ...

    Abstract Objective: The use of three-dimensional (3D) transvaginal ultrasonography (TVS) has been investigated for the diagnosis of deep endometriosis (DE). This study aimed to evaluate if 3D reconstructions improve the performance of TVS) in assessing the presence and characteristics of bladder endometriosis (BE).
    Design: This was a single-center comparative diagnostic accuracy study. Participants/Materials, Setting, Methods: Patients referred to our institution (Piazza della Vittoria 14 Srl, Genova, Italy) with clinical suspicion of DE were included. In case of surgery, women underwent systematic preoperative ultrasonographic imaging; an experienced sonographer performed a conventional TVS; another experienced sonographer, blinded to results of the previous exam, performed TVS, with the addition of 3D modality. The presence and characteristics of BE nodules were described in accord with International DE Analysis group consensus. Ultrasound data were compared with surgical and histological results.
    Results: Overall, BE was intraoperatively found in 34 out of 194 women who underwent surgery for DE (17.5%; 95% confidence interval: 12.8-23.5%). TVS without and with 3D reconstructions were able to detect endometriotic BE in 82.2% (n = 28/34) and 85.3% (n = 29/34) of the cases (p = 0.125). Both the exams similarly estimated the largest diameter of BE (p = 0.652) and the distance between the endometriotic nodule and the closest ureteral meatus (p = 0.341). However, TVS with 3D reconstructions was more precise in estimating the volume of BE (p = 0.031). In one case (2.9%), TVS without and with 3D reconstructions detected the infiltration of the intramural ureter, which was confirmed at surgery and required laparoscopic ureterovesical reimplantation.
    Limitations: The extensive experience of the gynecologists performing the ultrasonographic scans, the lack of prestudy power analysis, and the population selected, which may have been influenced by the position of the institution as a referral center specialized in the treatment of severe endometriosis, are limitations of the current study.
    Conclusion: Our results demonstrated the high accuracy of ultrasound for diagnosing BE. The addition of 3D reconstructions does not improve the performance of TVS in diagnosing the presence and characteristics of BE. However, the volume of BE may be more precisely assessed by 3D ultrasound.
    MeSH term(s) Endometriosis/diagnostic imaging ; Endometriosis/surgery ; Female ; Humans ; Prospective Studies ; Sensitivity and Specificity ; Ultrasonography ; Urinary Bladder
    Language English
    Publishing date 2021-06-22
    Publishing country Switzerland
    Document type Comparative Study ; Journal Article
    ZDB-ID 800003-7
    ISSN 1423-002X ; 0378-7346
    ISSN (online) 1423-002X
    ISSN 0378-7346
    DOI 10.1159/000516634
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Ultrasonography for bowel endometriosis.

    Ferrero, Simone / Barra, Fabio / Scala, Carolina / Condous, George

    Best practice & research. Clinical obstetrics & gynaecology

    2020  Volume 71, Page(s) 38–50

    Abstract: Transvaginal ultrasonography (TVS) should be the first-line investigation in patients with suspicion of deep endometriosis and, in particular, of rectosigmoid endometriosis. TVS cannot assess the presence of intestinal nodules located proximally to the ... ...

    Abstract Transvaginal ultrasonography (TVS) should be the first-line investigation in patients with suspicion of deep endometriosis and, in particular, of rectosigmoid endometriosis. TVS cannot assess the presence of intestinal nodules located proximally to the sigmoid (such as ileal or cecal endometriotic nodules), because these lesions are beyond the field of the transvaginal probe. The ultrasonographic findings of rectosigmoid endometriosis are the presence of an irregular hypoechoic nodule in the anterior wall of the rectosigmoid colon. The learning curve for diagnosing rectosigmoid endometriosis by TVS is quite short; approximately, 40 scans are required to a sonographer who trained in general gynecologic ultrasonography to become proficient at diagnosing bowel endometriosis. Several meta-analyses confirmed the high diagnostic performance of TVS in diagnosing rectosigmoid endometriosis. The presence of "soft markers" (negative sliding sign and kissing ovaries) facilitates the diagnosis of rectosigmoid endometriosis. Enhanced TVS (rectal water-contrast transvaginal ultrasonography, sonovaginography, and tenderness-guided transvaginal ultrasonography) does not improve the performance of TVS in diagnosing rectosigmoid endometriosis. These investigations, however, may be useful to ascertain the depth of infiltration of endometriosis in the intestinal wall or the presence of rectal stenosis. Magnetic resonance imaging has the same performance of TVS in diagnosing rectosigmoid endometriosis; however, it should be recommended as a second-line technique in the preoperative workup of patients with previous equivocal TVS findings.
    MeSH term(s) Endometriosis/diagnostic imaging ; Female ; Humans ; Magnetic Resonance Imaging ; Rectum/diagnostic imaging ; Sensitivity and Specificity ; Ultrasonography
    Language English
    Publishing date 2020-06-06
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2050090-7
    ISSN 1532-1932 ; 1521-6934
    ISSN (online) 1532-1932
    ISSN 1521-6934
    DOI 10.1016/j.bpobgyn.2020.05.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis.

    Barra, Fabio / Scala, Carolina / Leone Roberti Maggiore, Umberto / Ferrero, Simone

    Journal of clinical medicine

    2020  Volume 9, Issue 1

    Abstract: Background: Rectosigmoid endometriosis is a severe form of deep endometriosis, which may be responsible for pain symptoms and a wide range of intestinal complains such as diarrhea, constipation, and abdominal cramping. The primary objective of this ... ...

    Abstract Background: Rectosigmoid endometriosis is a severe form of deep endometriosis, which may be responsible for pain symptoms and a wide range of intestinal complains such as diarrhea, constipation, and abdominal cramping. The primary objective of this study was to evaluate the efficacy of long-term therapy with dienogest (DNG), a fourth-generation progestin, for ameliorating quality of life, pain, and intestinal symptoms of patients affected by rectosigmoid endometriosis.
    Methods: A retrospective analysis of a prospectively collected database was done on patients with endometriotic nodules infiltrating at least the muscular layer of the rectosigmoid wall with an estimated colorectal stenosis <60%. The diagnosis of rectosigmoid endometriosis was based on transvaginal ultrasonography. Patients accepting to participate in the study received continuous oral treatment with DNG at the dose of 2 mg/day.
    Results: At the end of the first year of treatment, a significant decrease in dysmenorrhea (
    Conclusion: The current study confirms the efficacy of long-term therapy with DNG for treating symptoms caused by rectosigmoid endometriosis.
    Language English
    Publishing date 2020-01-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm9010154
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.

    Barra, Fabio / Scala, Carolina / Ferrero, Simone

    Expert opinion on drug metabolism & toxicology

    2018  Volume 14, Issue 4, Page(s) 399–415

    Abstract: Introduction: Endometriosis is a chronic estrogen and progestogen responsive inflammatory disease associated with pain symptoms and infertility. The medical therapy of endometriosis aims to induce decidualization within the hormonally dependent ectopic ... ...

    Abstract Introduction: Endometriosis is a chronic estrogen and progestogen responsive inflammatory disease associated with pain symptoms and infertility. The medical therapy of endometriosis aims to induce decidualization within the hormonally dependent ectopic endometrium, and it is often administered to ameliorate women' pain symptoms or to prevent post-surgical disease recurrence. A variety of progestins have been used in monotherapy for the medical management of women with endometriosis. Areas covered: This review aims to offer the reader a complete overview of pharmacokinetic (PK) and clinical efficacy of progestins for the treatment of endometriosis. Expert opinion: Each progestin has a distinct PK parameters and pharmacodynamics affinity not only for progesterone receptor, but also for other steroid receptors, such as estrogen, androgen, and glucocorticoid. Moreover, progestins can also be delivered in different formulations. All these characteristics influence their final biological effect. Randomized, controlled, non-blinded studies support the use of oral progestin-only treatment for pelvic pain associated with endometriosis. Currently, the only two progestins approved by Food and Drug Administration (FDA) for the treatment of endometriosis are norethindrone acetate (NETA) and depot medroxyprogesterone acetate (DMPA).
    MeSH term(s) Administration, Oral ; Endometriosis/complications ; Endometriosis/drug therapy ; Endometriosis/physiopathology ; Female ; Humans ; Medroxyprogesterone Acetate/therapeutic use ; Norethindrone/analogs & derivatives ; Norethindrone/therapeutic use ; Pelvic Pain/drug therapy ; Pelvic Pain/etiology ; Progestins/adverse effects ; Progestins/pharmacokinetics ; Progestins/therapeutic use ; Randomized Controlled Trials as Topic ; Receptors, Steroid/drug effects ; Receptors, Steroid/metabolism
    Chemical Substances Progestins ; Receptors, Steroid ; norethindrone acetate (9S44LIC7OJ) ; Medroxyprogesterone Acetate (C2QI4IOI2G) ; Norethindrone (T18F433X4S)
    Language English
    Publishing date 2018-04
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2214462-6
    ISSN 1744-7607 ; 1742-5255
    ISSN (online) 1744-7607
    ISSN 1742-5255
    DOI 10.1080/17425255.2018.1461840
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Inhibitory kappa B alpha expression in endometriosis.

    Barra, Fabio / Desideri, Lorenzo Ferro / Scala, Carolina / Ferrero, Simone

    Turkish journal of obstetrics and gynecology

    2019  Volume 15, Issue 4, Page(s) 277–278

    Language English
    Publishing date 2019-01-09
    Publishing country Turkey
    Document type Journal Article
    ISSN 2149-9322
    ISSN 2149-9322
    DOI 10.4274/tjod.37801
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Transvaginal ultrasound-guided biopsy of adenomyosis.

    Ferrero, Simone / Scala, Carolina / Vellone, Valerio Gaetano / Biscaldi, Ennio / Barra, Fabio

    Annals of translational medicine

    2020  Volume 7, Issue Suppl 8, Page(s) S341

    Language English
    Publishing date 2020-01-03
    Publishing country China
    Document type Editorial ; Comment
    ZDB-ID 2893931-1
    ISSN 2305-5847 ; 2305-5839
    ISSN (online) 2305-5847
    ISSN 2305-5839
    DOI 10.21037/atm.2019.09.94
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Magnetic Resonance Rectal Enema Versus Computed Tomographic Colonography in the Diagnosis of Rectosigmoid Endometriosis.

    Biscaldi, Ennio / Barra, Fabio / Scala, Carolina / Stabilini, Cesare / Vellone, Valerio Gaetano / Ferrero, Simone

    Journal of computer assisted tomography

    2020  Volume 44, Issue 4, Page(s) 501–510

    Abstract: Objectives: Rectosigmoid involvement by endometriosis causes intestinal symptoms such as constipation, diarrhea, and dyschezia. A precise diagnosis about the presence, location, and extent of bowel implants is required to plan the most appropriate ... ...

    Abstract Objectives: Rectosigmoid involvement by endometriosis causes intestinal symptoms such as constipation, diarrhea, and dyschezia. A precise diagnosis about the presence, location, and extent of bowel implants is required to plan the most appropriate treatment. The aim of the study was to compare the accuracy of magnetic resonance with distension of the rectosigmoid (MR-e) with computed colonography (CTC) for diagnosing rectosigmoid endometriosis.
    Methods: This study was based on the retrospective analysis of a prospectively collected database of patients with suspicion of rectosigmoid endometriosis who underwent both MR-e and CTC, and subsequently were treated by laparoscopy. The findings of imaging techniques were compared with surgical and histological results.
    Results: Of 90 women included in the study, 44 (48.9%) had rectosigmoid nodules and underwent bowel surgery. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for the diagnosis of rectosigmoid endometriosis were 88.6%, 93.5%, 92.9%, 89.6%, and 91.1% for CTC, and 93.2%, 97.9%, 97.6%, 93.8%, and 95.6% for MR-e. There was no significant difference in the accuracy of both radiologic examinations for diagnosing rectosigmoid endometriosis (P = 0.344). However, MR-e was more accurate than CTC in estimating the largest diameter of the main rectosigmoid nodule (P < 0.001). The pain perceived by the patients was significantly lower during MR-e than during CTC (P < 0.001).
    Conclusions: MR-e and CTC have similar diagnostic performance for the diagnosis of rectosigmoid involvement of endometriosis. However, MR-e is more accurate in the estimation of the largest diameter of main rectosigmoid nodule and more tolerated than CTC.
    MeSH term(s) Adult ; Colon, Sigmoid/diagnostic imaging ; Colon, Sigmoid/pathology ; Colonography, Computed Tomographic/methods ; Endometriosis/diagnostic imaging ; Enema/methods ; Female ; Humans ; Magnetic Resonance Imaging ; Prospective Studies ; Rectum/diagnostic imaging ; Rectum/pathology ; Retrospective Studies ; Sensitivity and Specificity
    Language English
    Publishing date 2020-06-17
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 80392-3
    ISSN 1532-3145 ; 0363-8715
    ISSN (online) 1532-3145
    ISSN 0363-8715
    DOI 10.1097/RCT.0000000000001031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Fertility in patients with untreated rectosigmoid endometriosis.

    Ferrero, Simone / Scala, Carolina / Biscaldi, Ennio / Racca, Annalisa / Leone Roberti Maggiore, Umberto / Barra, Fabio

    Reproductive biomedicine online

    2020  Volume 42, Issue 4, Page(s) 757–767

    Abstract: Research question: Several studies have investigated reproductive outcomes following surgical treatment of colorectal endometriosis, mainly segmental colorectal resection. This study examines pregnancy and live birth rates of women with rectosigmoid ... ...

    Abstract Research question: Several studies have investigated reproductive outcomes following surgical treatment of colorectal endometriosis, mainly segmental colorectal resection. This study examines pregnancy and live birth rates of women with rectosigmoid endometriosis not treated by surgery.
    Design: A retrospective analysis of data collected between May 2009 and January 2020 related to 215 women affected by rectosigmoid endometriosis wishing to conceive. Patients had a diagnosis of rectosigmoid endometriosis by transvaginal ultrasonography and magnetic resonance imaging enema. Patients with estimated bowel stenosis >70% at computed tomographic colonography and/or subocclusive/occlusive symptoms were excluded.
    Results: During the median length of follow-up of 31 months (range 13-63 months), the total pregnancy and live birth rates of the study population were 47.9% and 45.1%, respectively. Sixty-two women had a live birth after natural conception (28.8%; 95% confidence interval [CI] 22.8-35.6%) with a median time required to conceive of 10 months (range 2-34 months). Eighty-three women underwent infertility treatments (38.6%, 95% CI 32.1-45.5%); among these, 68 patients underwent IVF either directly (n = 51) or after intrauterine insemination (IUI) failure (n = 17). Time to conception was significantly higher in women having conceived by IVF than in those having conceived naturally (P < 0.001) or by IUI (P = 0.006). In patients undergoing IVF cycles, a worsening of some pain and intestinal symptoms was observed.
    Conclusions: At median follow-up of 31 months, women with rectosigmoid endometriosis have a 48% pregnancy rate. However, these patients must be referred to centres specialized in managing endometriosis to properly assess symptoms and degree of bowel stenosis.
    MeSH term(s) Adult ; Endometriosis/epidemiology ; Female ; Fertility ; Fertilization in Vitro/statistics & numerical data ; Humans ; Italy/epidemiology ; Pregnancy ; Pregnancy Rate ; Rectal Diseases/epidemiology ; Retrospective Studies ; Sigmoid Diseases/epidemiology
    Language English
    Publishing date 2020-12-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2113823-0
    ISSN 1472-6491 ; 1472-6483
    ISSN (online) 1472-6491
    ISSN 1472-6483
    DOI 10.1016/j.rbmo.2020.12.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle.

    Barra, Fabio / Laganà, Antonio Simone / Scala, Carolina / Garzon, Simone / Ghezzi, Fabio / Ferrero, Simone

    Reproductive biomedicine online

    2020  Volume 41, Issue 5, Page(s) 859–868

    Abstract: Research question: The major causes of IVF failure in women with endometriosis have been attributed to decreased ovarian reserve, low embryo quality and impaired receptivity of the endometrium. Dienogest (DNG) has anti-inflammatory and anti-angiogenic ... ...

    Abstract Research question: The major causes of IVF failure in women with endometriosis have been attributed to decreased ovarian reserve, low embryo quality and impaired receptivity of the endometrium. Dienogest (DNG) has anti-inflammatory and anti-angiogenic activity and so may theoretically improve IVF outcomes in women with endometriosis. This study aimed to evaluate the administration of DNG before IVF in women with endometriosis who had previously failed one IVF cycle.
    Methods: This study was based on the retrospective analysis of a prospectively collected database, including 151 women who had failed a previous IVF cycle and all subsequent embryo transfers and had an imaging diagnosis of endometriosis. Patients either directly underwent IVF without receiving hormonal treatment or received 3 months of treatment with DNG (2 mg/daily) before IVF.
    Results: Eighty-eight (58.3%) patients underwent IVF without previous hormonal treatment, and 63 (41.7%) received pretreatment with DNG. The cumulative implantation, clinical pregnancy and live birth rates were significantly higher in the DNG-treated group (39.7%, 33.3% and 28.6%) than in the non-treated group (23.9%, 18.2% and 14.8%; P = 0.049, 0.037 and 0.043, respectively). The largest diameter of endometriomas significantly decreased after DNG pretreatment (P < 0.001). The use of DNG increased significantly the number of oocytes retrieved (P = 0.031), two-pronuclear embryos (P = 0.039) and blastocysts (P = 0.005) in women with endometriomas of diameter ≥4 cm.
    Conclusions: This study suggest that in patients with endometriosis, IVF outcomes can be improved by pretreatment with DNG. In particular, the use of DNG allows for better oocyte retrieval and blastocysts in patients with large endometriomas.
    MeSH term(s) Adult ; Birth Rate ; Embryo Transfer ; Endometriosis/drug therapy ; Female ; Fertilization in Vitro/methods ; Hormone Antagonists/therapeutic use ; Humans ; Nandrolone/analogs & derivatives ; Nandrolone/therapeutic use ; Oocyte Retrieval ; Ovulation Induction/methods ; Pregnancy ; Pregnancy Rate ; Retrospective Studies
    Chemical Substances Hormone Antagonists ; dienogest (46M3EV8HHE) ; Nandrolone (6PG9VR430D)
    Language English
    Publishing date 2020-07-26
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2113823-0
    ISSN 1472-6491 ; 1472-6483
    ISSN (online) 1472-6491
    ISSN 1472-6483
    DOI 10.1016/j.rbmo.2020.07.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Regarding "Does Ulipristal Acetate Affect Surgical Experience at Laparoscopic Myomectomy?"

    Ferrero, Simone / Scala, Carolina / Barra, Fabio

    Journal of minimally invasive gynecology

    2017  Volume 25, Issue 3, Page(s) 541

    MeSH term(s) Female ; Humans ; Laparoscopy ; Leiomyoma/surgery ; Norpregnadienes ; Uterine Myomectomy
    Chemical Substances Norpregnadienes ; ulipristal acetate (YF7V70N02B)
    Language English
    Publishing date 2017-11-23
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2186934-0
    ISSN 1553-4669 ; 1553-4650
    ISSN (online) 1553-4669
    ISSN 1553-4650
    DOI 10.1016/j.jmig.2017.10.038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top